Beta-blockers in the treatment of heart failure. CIBIS III Trial
Journal Title: Przewodnik Lekarza - Year 2005, Vol 82, Issue 10
Abstract
Heart failure is a very important problem in health care system. In Europe there are almost 10 millions and in Poland half a million patients with left ventricular dysfunction. Heart failure is a clinical disorder characterized by insufficient perfusion of peripheral tissues and fluid retention. Improvement of heart contractility is one of the major therapeutic aims among patients with left ventricular dysfunction. The exact knowledge of methods of heart assistance is indispensable in practice both cardiologist, cardiac surgeons and general practitioners. Beta-blockers are the most important medicines used in the treatment of heart failure. Each new clinical trial informs about the additional benefits resulting of their application. The similarly effect we have already observed during recent presentation of CIBIS III.
Authors and Affiliations
Maciej Banach, Marcin Barylski, Jarosław Drożdż
Keywords
Related Articles
- EP ID EP112777
- DOI -
- Views 87
- Downloads 0
Rzadkie formy cukrzycy u dzieci i młodzieży
Zdecydowana większość przypadków cukrzycy rozpoznawanych wśród pacjentów pediatrycznych to autoimmunologiczna cukrzyca typu 1. Jednak w tej grupie wiekowej coraz częściej rozpoznaje się przypadki monogenowych form chor...
Zastosowanie długo działających β2-mimetyków (LABA) i wziewnych glikokortykosteroidów (WGKS) w leczeniu astmy i przewlekłej obturacyjnej choroby płuc (POChP)
Lekami najsilniej rozszerzającymi oskrzela są agoniści receptora β2-adrenergicznego. Obecnie dostępne leki o długim czasie działania są powszechnie stosowane w leczeniu astmy i POChP. Jednak stosowanie tylko tych leków...
Prognostic factors in chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is one of the most prevalent chronic diseases in the world. In developed countries it is mainly caused by smoking. COPD became one of the most common causes of mortality and i...
Arterial hypertension - significant problem in patients with diabetes mellitus
The incidence of hypertension in diabetes is 2-3 frequently than in whole human population. It is often connected with diabetic nephropathy, which is leading to end-stage renal disease, so antihypertensive treatment sh...
Metabolic syndrome - time for a critical view
The term metabolic syndrome refers to specific cardiovascular risk factors whose underlying pathophysiology is thought to be related to insulin resistance. Insulin resistance is also found to be a key feature of type 2 d...